Reloading patients chronically treated with P2Y12 inhibitors and presenting with ACS/PCI: Facing a crossroad?

被引：0
|
作者：
Alexopoulos, Dimitrios [1 ]
机构：
[1] Patras Univ Hosp, Dept Cardiol, Patras 26500, Greece
来源：
INTERNATIONAL JOURNAL OF CARDIOLOGY | 2013年 / 167卷 / 01期
关键词：
Clopidogrel; Prasugrel; Ticagrelor; Acute coronary syndrome; Percutaneous coronary intervention; Reloading; CHRONIC CLOPIDOGREL THERAPY; PERCUTANEOUS CORONARY INTERVENTION; ANTIPLATELET THERAPY; PLATELET INHIBITION; ANGIOPLASTY; TICAGRELOR; PRASUGREL;
D O I：
10.1016/j.ijcard.2012.09.202
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
[No abstract available]
引用
收藏
页码：292 / 293
页数：2
相关论文
共 50 条
  • [41] P2Y12 Inhibitors in Patients With Chronic Kidney Disease The Known Unknown
    Gurm, Hitinder S.
    JACC-CARDIOVASCULAR INTERVENTIONS, 2017, 10 (20) : 2026 - 2028
  • [42] P2Y12 inhibitors adjunctive to primary PCI therapy in STEMI: Fighting against the activated platelets
    Alexopoulos, Dimitrios
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2013, 163 (03) : 249 - 255
  • [43] Factors Affecting Platelet Reactivity and Cardiovascular Outcome in CAD Patients Treated With P2Y12 Receptor Inhibitors
    Siasos, Gerasimos
    Stefanadis, Christodoulos
    Tousoulis, Dimitris
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2016, 68 (01) : 134 - 134
  • [44] TIME DELAY FROM SYMPTOM ONSET-TO-REPERFUSION AND LABORATORY EFFICACY OF P2Y12 INHIBITORS IN PATIENTS WITH STE: MYOCARDIAL INFARCTION TREATED WITH PRIMARY PCI
    Motovska, Zuzana
    Martina, Ondrakova
    Vichova, Teodora
    Knot, Jiri
    Bednar, Frantisek
    Ulman, Jaroslav
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2014, 63 (12) : A107 - A107
  • [45] Assessment of P2Y12 inhibition with the point-of-care device VerifyNow P2Y12 in patients treated with prasugrel or clopidogrel coadministered with aspirin
    Varenhorst, Christoph
    James, Stefan
    Erlinge, David
    Braun, Oscar O.
    Brandt, John T.
    Winters, Kenneth J.
    Jakubowski, Joseph A.
    Olofsson, Sylvia
    Wallentin, Lars
    Slegbahn, Agneta
    AMERICAN HEART JOURNAL, 2009, 157 (03) : 562.e1 - 562.e9
  • [46] P2Y12 Receptor Inhibitors in ACS Management with or without ST-segment Elevation, Literature Review
    Aljohani, Abdulrahman Mousa
    Aljuhani, Moaath Saleh
    Almalki, Khalid Dhaifallah
    Alhazmi, Ghassan Abdullah
    Ghaith, Anas Mohammed
    Bardisi, Alwaleed Khalid
    Aljohani, Muhannad Abdulrahim
    Alsehli, Marwan Naif
    Aljohani, Badr Salem
    Alahmadi, Hassan Sulaiman
    INTERNATIONAL JOURNAL OF PHARMACEUTICAL RESEARCH AND ALLIED SCIENCES, 2021, 10 (03): : 137 - 140
  • [47] Thrombus remodelling by reversible and irreversible P2Y12 inhibitors
    Tunstromer, Kjersti
    Faxalv, Lars
    Larsson, Pia
    Lindahl, Tomas L.
    Boknas, Niklas
    PLATELETS, 2023, 34 (01)
  • [48] Guided and unguided de-escalation from potent P2Y12 inhibitors among patients with ACS: a meta-analysis
    Tavenier, A. H.
    Chiarito, M.
    Cao, D.
    Pivato, C. A.
    Nicolas, J.
    Nardin, M.
    Sartori, S.
    Baber, U.
    Angiolillo, D. J.
    Capodanno, D.
    Kini, A. S.
    Sharma, S. K.
    Dangas, G.
    Mehran, R.
    EUROPEAN HEART JOURNAL, 2021, 42 : 1427 - 1427
  • [49] Republished Education in Heart: New P2Y12 inhibitors
    Storey, Robert F.
    POSTGRADUATE MEDICAL JOURNAL, 2012, 88 (1035) : 49 - 54
  • [50] P2Y12 Inhibitors in Cardiovascular Disease: Focus on Prasugrel
    Scott, Day Marice
    Norwood, Rhonda M.
    Parra, David
    ANNALS OF PHARMACOTHERAPY, 2009, 43 (01) : 64 - 76
12345